Cardiovascular management of septic shock in 2012

Maria Cristina Vazquez Guillamet, Chanu Rhee, Andrew J Patterson

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Septic shock is a major cause of morbidity and mortality throughout the world. Source control, antimicrobial therapy, early goal-directed fluid resuscitation, and infusion of vasoactive pharmaceuticals remain the cornerstones of treatment. However, the cardiovascular management of septic shock is evolving. Basic science and clinical researchers have identified novel drug targets and are testing the efficacy of new therapeutic agents. For example, prevention of microvascular leak during septic shock is the focus of active investigations and may soon provide considerable benefit to patients. Among the important topics that will be discussed in this review are the following: the role of vascular endothelial dysfunction in microvascular leak, the impact of cytokines upon structural and functional proteins within the endothelial barrier and within the heart, and the ability of selective vasopressin 1a receptor agonists to minimize tissue edema and improve hemodynamic status.

Original languageEnglish (US)
Pages (from-to)493-502
Number of pages10
JournalCurrent Infectious Disease Reports
Volume14
Issue number5
DOIs
StatePublished - Oct 1 2012

Fingerprint

Septic Shock
Vasopressin Receptors
Resuscitation
Pharmaceutical Preparations
Blood Vessels
Edema
Therapeutics
Hemodynamics
Research Personnel
Cytokines
Morbidity
Mortality
Proteins

Keywords

  • Capillary leak
  • Cardiovascular
  • Fluid resuscitation
  • Hypotension
  • Septic cardiomyopathy
  • Septic shock
  • V1a receptor agonist
  • Vascular endothelium
  • Vascular tone
  • Vasoactive pharmaceuticals
  • Vasopressin

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Cardiovascular management of septic shock in 2012. / Guillamet, Maria Cristina Vazquez; Rhee, Chanu; Patterson, Andrew J.

In: Current Infectious Disease Reports, Vol. 14, No. 5, 01.10.2012, p. 493-502.

Research output: Contribution to journalReview article

Guillamet, Maria Cristina Vazquez ; Rhee, Chanu ; Patterson, Andrew J. / Cardiovascular management of septic shock in 2012. In: Current Infectious Disease Reports. 2012 ; Vol. 14, No. 5. pp. 493-502.
@article{deb2c971fb324711bbc536a2ee92444e,
title = "Cardiovascular management of septic shock in 2012",
abstract = "Septic shock is a major cause of morbidity and mortality throughout the world. Source control, antimicrobial therapy, early goal-directed fluid resuscitation, and infusion of vasoactive pharmaceuticals remain the cornerstones of treatment. However, the cardiovascular management of septic shock is evolving. Basic science and clinical researchers have identified novel drug targets and are testing the efficacy of new therapeutic agents. For example, prevention of microvascular leak during septic shock is the focus of active investigations and may soon provide considerable benefit to patients. Among the important topics that will be discussed in this review are the following: the role of vascular endothelial dysfunction in microvascular leak, the impact of cytokines upon structural and functional proteins within the endothelial barrier and within the heart, and the ability of selective vasopressin 1a receptor agonists to minimize tissue edema and improve hemodynamic status.",
keywords = "Capillary leak, Cardiovascular, Fluid resuscitation, Hypotension, Septic cardiomyopathy, Septic shock, V1a receptor agonist, Vascular endothelium, Vascular tone, Vasoactive pharmaceuticals, Vasopressin",
author = "Guillamet, {Maria Cristina Vazquez} and Chanu Rhee and Patterson, {Andrew J}",
year = "2012",
month = "10",
day = "1",
doi = "10.1007/s11908-012-0279-z",
language = "English (US)",
volume = "14",
pages = "493--502",
journal = "Current Infectious Disease Reports",
issn = "1523-3847",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Cardiovascular management of septic shock in 2012

AU - Guillamet, Maria Cristina Vazquez

AU - Rhee, Chanu

AU - Patterson, Andrew J

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Septic shock is a major cause of morbidity and mortality throughout the world. Source control, antimicrobial therapy, early goal-directed fluid resuscitation, and infusion of vasoactive pharmaceuticals remain the cornerstones of treatment. However, the cardiovascular management of septic shock is evolving. Basic science and clinical researchers have identified novel drug targets and are testing the efficacy of new therapeutic agents. For example, prevention of microvascular leak during septic shock is the focus of active investigations and may soon provide considerable benefit to patients. Among the important topics that will be discussed in this review are the following: the role of vascular endothelial dysfunction in microvascular leak, the impact of cytokines upon structural and functional proteins within the endothelial barrier and within the heart, and the ability of selective vasopressin 1a receptor agonists to minimize tissue edema and improve hemodynamic status.

AB - Septic shock is a major cause of morbidity and mortality throughout the world. Source control, antimicrobial therapy, early goal-directed fluid resuscitation, and infusion of vasoactive pharmaceuticals remain the cornerstones of treatment. However, the cardiovascular management of septic shock is evolving. Basic science and clinical researchers have identified novel drug targets and are testing the efficacy of new therapeutic agents. For example, prevention of microvascular leak during septic shock is the focus of active investigations and may soon provide considerable benefit to patients. Among the important topics that will be discussed in this review are the following: the role of vascular endothelial dysfunction in microvascular leak, the impact of cytokines upon structural and functional proteins within the endothelial barrier and within the heart, and the ability of selective vasopressin 1a receptor agonists to minimize tissue edema and improve hemodynamic status.

KW - Capillary leak

KW - Cardiovascular

KW - Fluid resuscitation

KW - Hypotension

KW - Septic cardiomyopathy

KW - Septic shock

KW - V1a receptor agonist

KW - Vascular endothelium

KW - Vascular tone

KW - Vasoactive pharmaceuticals

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=84870531304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870531304&partnerID=8YFLogxK

U2 - 10.1007/s11908-012-0279-z

DO - 10.1007/s11908-012-0279-z

M3 - Review article

VL - 14

SP - 493

EP - 502

JO - Current Infectious Disease Reports

JF - Current Infectious Disease Reports

SN - 1523-3847

IS - 5

ER -